Boardroom Alpha
8-K primary document
NSYS · Current Report (Form 8-K) · Filed January 6, 2026

Nortech Systems Inc8-K exhibit

ex99-1.htm

 

Exhibit 99.1

 

Nortech Systems Names Andrew Walko

 

Senior Vice President of Global Operations

 

MINNEAPOLIS, January 6, 2026 — Nortech Systems Incorporated (Nasdaq: NSYS) (“Nortech” or the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, industrial, and aerospace & defense markets, announced today that Andrew Walko has been named Senior Vice President of Global Operations.

 

“We welcome Andrew to the Nortech team and are confident that he will provide exceptional leadership to drive the Company’s strategic initiatives,” said Jay D. Miller, President and CEO of Nortech Systems. “Andrew brings extensive experience in the medical device field that aligns perfectly with Nortech’s mission to deliver exceptional value by solving complex challenges in the critical markets we serve. We know Andrew well and we’re thrilled to have him join the Nortech team.”

 

Walko has extensive experience in the medical device industry including top-level executive roles at Sanuwave and Biomerics, as well as senior manufacturing operations leadership roles at Minnetronix. “I look forward to collaborating with the talented individuals here to build on our collective strengths, drive strategic growth, and deliver exceptional value to our customers and stakeholders,” said Walko.

 

In his new role, Walko will replace John Lindeen, who is retiring in the first quarter of 2026, and will be responsible for overseeing the Company’s global operations, including Nortech’s facilities in the U.S., Mexico and China, as well as the Company’s global supply chain, new product introductions, production planning and on-time delivery. Walko will work closely with Nortech’s senior leadership team and board of directors to optimize the Company’s near-shoring strategy and manufacturing capacity while minimizing risk and driving performance improvement. Walko will focus on partnering closely with customers to drive shorter lead times, tailored on-time delivery strategies, high quality standards, supply chain risk mitigation, and cost productivity, along with deeper innovative customer partnerships that are fundamental to Nortech’s long-term growth.

 

Nortech specializes in complex cable harnesses, printed circuit board assemblies (PCBAs) and box builds for low-volume, high-mix global manufacturing. In recent years, Nortech’s strategic investments in the U.S., Mexico and China coupled with important measures to focus on growing EBITDA while developing research and innovation have diversified the company’s capabilities and improved efficiencies to enhance profitability and support future growth.

 

###

 

About Nortech Systems Incorporated

 

Nortech Systems is a leading provider of design and manufacturing solutions for complex electromedical devices, electromechanical systems, assemblies, and components. Nortech primarily serves the medical imaging, medical device, aerospace & defense, and industrial markets. Its design services span concept development to commercial design, and include medical device, software, electrical, mechanical, and biomedical engineering. Its manufacturing and supply chain capabilities are vertically integrated around wire, cable, and interconnect assemblies, printed circuit board assemblies, as well as system-level assembly, integration, and final test. Headquartered in Maple Grove, Minn., Nortech currently has six manufacturing locations and design centers across the U.S., Latin America, and Asia. Nortech Systems is traded on the NASDAQ Stock Market under the symbol NSYS. Nortech’s website is www.nortechsys.com.

 

Contact

 

Andrew D. C. LaFrence

Chief Financial Officer and Senior Vice President of Finance
alafrence@nortechsys.com

952-345-2243

 

 

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer